Mediastinal mass — evaluation
compartment-based work-up · Respiratory
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Mediastinal masses are evaluated by anatomical compartment (anterior, middle, posterior), which narrows the differential. Priorities are excluding airway/vascular compromise, obtaining tissue safely, and identifying treatable causes such as lymphoma, germ-cell tumour and thymoma.
Red flags
- Stridor or positional dyspnoea (airway compression)
- Superior vena cava obstruction (facial swelling, distended veins)
- Haemodynamic compromise supine
- Rapidly enlarging mass with systemic symptoms
Assessment
Differential diagnosis
- Anterior: thymoma, lymphoma, germ-cell tumour, thyroid (the '4 Ts')
- Middle: lymphadenopathy, bronchogenic cyst, vascular anomaly
- Posterior: neurogenic tumour
- Sarcoidosis / reactive lymphadenopathy
- Metastatic disease
Investigations
- Contrast CT chest to localise compartment and characterise the mass
- Tumour markers (AFP, beta-hCG, LDH) for germ-cell tumour/lymphoma
- MRI for posterior/neurogenic or vascular lesions
- Tissue sampling (EBUS/core biopsy/mediastinoscopy) as appropriate
- Assess for superior vena cava obstruction and airway compromise
- Acetylcholine-receptor antibodies if thymoma/myasthenia suspected
Management
- Assess urgently for airway compromise and superior vena cava obstruction
- Localise the mass to a mediastinal compartment on CT
- Build a compartment-based differential diagnosis
- Send tumour markers (AFP, beta-hCG, LDH) before biopsy where germ-cell tumour/lymphoma possible
- Evaluate for myasthenia gravis if an anterior thymic lesion is present
- Plan the safest, most informative tissue biopsy with MDT input
- Avoid unnecessary sedation/anaesthesia with a large anterior mass risking airway collapse
- Treat chemosensitive tumours (lymphoma, germ-cell) medically once diagnosed
- Refer resectable thymoma/neurogenic tumours for surgery
- Manage emergencies (SVC obstruction, airway) per dedicated pathways
Drugs & doses
No empirical drug before tissue diagnosis (avoid steroids that can mask lymphoma histology)
Treat confirmed lymphoma/germ-cell tumour with cause-specific chemotherapy
Corticosteroids / SVC stenting for symptomatic superior vena cava obstruction
Manage myasthenia gravis with pyridostigmine/immunotherapy if confirmed
Disposition
Urgent thoracic MDT; airway/SVC emergency pathway if compromised; cause-directed treatment after safe tissue diagnosis.
Complications & pitfalls
- Airway collapse under anaesthesia (anterior mediastinal mass syndrome)
- Superior vena cava obstruction
- Cardiac/great-vessel compression
- Diagnostic delay for treatable malignancy
Exam pearls
- Avoid giving corticosteroids before biopsy if lymphoma is possible — they can obscure the histology
- A large anterior mediastinal mass can collapse the airway under general anaesthesia — plan carefully
- Measure AFP/beta-hCG before invasive procedures for possible germ-cell tumour
- Anterior-compartment '4 Ts': thymoma, teratoma/germ-cell, (terrible) lymphoma, thyroid
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.